Skip to content
PubMed This is a summary of 35 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 35 referenced papers

Top Authors

Clemens Bergwitz
Yale University
Dirk Schnabel
Charité - Universitätsmedizin Berlin
Dieter Haffner
Medizinische Hochschule Hannover
Giampiero Igli Baroncelli
University of Pisa
Kathryn McCrystal Dahir
Vanderbilt University Medical Center
Peter J. Tebben
Mayo Clinic
Stephanie Christensen
University of California Davis Medical Center
Juan Manuel Colazo
Vanderbilt University
Svetlana Papizh
Pirogov Russian National Research Medical University

Top Institutions

Ranked by publications Top 10 institutions
03

Charité - Universitätsmedizin Berlin

Berlin, Germany

11 papers
04
07

Vanderbilt University

Nashville, United States

7 papers
08

McMaster University

Hamilton, Canada

5 papers
09

Vanderbilt University Medical Center

Nashville, United States

5 papers
10

Pirogov Russian National Research Medical University

Moscow, Russia

2 papers
Contributors Svetlana Papizh

References

References (35)
  1. 1

    Rare inherited disorders with renal involvement-approach to the patient.

    Joly D, Béroud C, Grünfeld JP

    Kidney international 2015; (87(5)):901-8 doi:10.1038/ki.2014.432.

    PMID: 25651365
  2. 2

    Hypercalcemic Disorders in Children.

    Stokes VJ, Nielsen MF, Hannan FM, Thakker RV

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2017; (32(11)):2157-2170 doi:10.1002/jbmr.3296.

    PMID: 28914984
  3. 3

    Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

    Wagner CA, Rubio-Aliaga I, Hernando N

    Pediatric nephrology (Berlin, Germany) 2019; (34(4)):549-559 doi:10.1007/s00467-017-3873-3.

    PMID: 29275531
  4. 4

    SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria

    Hasani-Ranjbar S, Ejtahed HS, Amoli MM, et al.

    Journal of clinical research in pediatric endocrinology 2018; (10(4)):343-349 doi:10.4274/jcrpe.0057.

    PMID: 29809158
  5. 5

    Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

    Bergwitz C, Miyamoto KI

    Pflugers Archiv : European journal of physiology 2019; (471(1)):149-163 doi:10.1007/s00424-018-2184-2.

    PMID: 30109410
  6. 6

    Evaluating pathogenicity of SLC34A3-Ser192Leu, a frequent European missense variant in disorders of renal phosphate wasting.

    Schönauer R, Petzold F, Lucinescu W, et al.

    Urolithiasis 2019; (47(6)):511-519 doi:10.1007/s00240-019-01116-2.

    PMID: 30798342
  7. 7

    Phosphate matters when investigating hypercalcemia: a mutation in SLC34A3 causing HHRH

    Tang AR, Hinz LE, Khan A, Kline GA

    Endocrinology, diabetes & metabolism case reports 2019; (2019(1)):1-6 doi:10.1530/EDM-19-0058.

    PMID: 31352694
  8. 8

    Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives.

    Raimann A, Mindler GT, Kocijan R, et al.

    Wiener medizinische Wochenschrift (1946) 2020; (170(5-6)):116-123 doi:10.1007/s10354-019-00732-2.

    PMID: 31993875
  9. 9

    [Clinical feature and variant analysis of a case with hereditary hypophosphatemic rickets with hypercalciuria].

    Liu L, Gao X, Ma Y, et al.

    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2020; (37(6)):637-640 doi:10.3760/cma.j.issn.1003-9406.2020.06.010.

    PMID: 32472541
  10. 10

    HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA: A NOVEL HOMOZYGOUS MUTATION IN SLC34A3 AND LITERATURE REVIEW.

    Bhadada SK, Sridhar S, Dhiman V, et al.

    AACE clinical case reports 2020; (6(3)):e105-e112 doi:10.4158/ACCR-2019-0456.

    PMID: 32524022
  11. 11

    Metabolic risk factors in children with kidney stone disease: an update.

    Spivacow FR, Del Valle EE, Boailchuk JA, et al.

    Pediatric nephrology (Berlin, Germany) 2020; (35(11)):2107-2112 doi:10.1007/s00467-020-04660-x.

    PMID: 32564280
  12. 12

    Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) Presenting with Genu Valgum Deformity: Treatment with Phosphate Supplementation and Surgical Correction.

    Colazo JM, Reasoner SA, Holt G, et al.

    Case reports in endocrinology 2020; (2020()):1047327 doi:10.1155/2020/1047327.

    PMID: 32695531
  13. 13

    Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study.

    Solak V, Gökce Mİ, Yaman Ö

    International urology and nephrology 2021; (53(9)):1791-1796 doi:10.1007/s11255-021-02879-7.

    PMID: 33904027
  14. 14

    X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management.

    Baroncelli GI, Mora S

    Frontiers in endocrinology 2021; (12()):688309 doi:10.3389/fendo.2021.688309.

    PMID: 34421819
  15. 15

    Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature.

    Christensen S, Tebben PJ, Sas D, Creo AL

    Hormone research in paediatrics 2021; (94(9-10)):374-389 doi:10.1159/000520299.

    PMID: 34666334
  16. 16

    Rickets guidance: part II-management.

    Haffner D, Leifheit-Nestler M, Grund A, Schnabel D

    Pediatric nephrology (Berlin, Germany) 2022; (37(10)):2289-2302 doi:10.1007/s00467-022-05505-5.

    PMID: 35352187
  17. 17

    Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.

    Pignolo RJ, Bedford-Gay C, Cali A, et al.

    Orphanet journal of rare diseases 2022; (17(1)):168 doi:10.1186/s13023-022-02224-w.

    PMID: 35436894
  18. 18

    Growth hormone therapy in HHRH.

    Filler G, Schott C, Salerno FR, et al.

    Bone reports 2022; (16()):101591 doi:10.1016/j.bonr.2022.101591.

    PMID: 35663378
  19. 19

    Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).

    Stürznickel J, Heider F, Delsmann A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(8)):1580-1591 doi:10.1002/jbmr.4630.

    PMID: 35689455
  20. 20

    Whole Body, Whole Life, Whole Family: Patients' Perspectives on X-Linked Hypophosphatemia.

    Hamilton AA, Faitos S, Jones G, et al.

    Journal of the Endocrine Society 2022; (6(8)):bvac086 doi:10.1210/jendso/bvac086.

    PMID: 35860754
  21. 21

    Carer burden in rare inherited diseases: a literature review and conceptual model.

    Sandilands K, Williams A, Rylands AJ

    Orphanet journal of rare diseases 2022; (17(1)):428 doi:10.1186/s13023-022-02561-w.

    PMID: 36494728
  22. 22

    SLC34A3 GENE MUTATION AS A RARE CAUSE OF HYPOPHOSPHATEMIA IN TWO SIBLINGS.

    Karakilic-Ozturan E, Ozturk AP, Oney C, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2022; (18(3)):387-391 doi:10.4183/aeb.2022.387.

    PMID: 36699160
  23. 23

    Novel Variant of SLC34A3 in a Compound Heterozygous Brazilian Girl with Hereditary Hypophosphatemic Rickets with Hypercalciuria

    Valadares LP, de Carvalho DR

    Journal of clinical research in pediatric endocrinology 2025; (17(3)):326-331 doi:10.4274/jcrpe.galenos.2023.2023-5-2.

    PMID: 37680384
  24. 24

    Genu Valgum, Fractures, and Renal Stones in a 10-year-old Girl.

    Christensen S, Loomba LA

    JCEM case reports 2023; (1(1)):luac022 doi:10.1210/jcemcr/luac022.

    PMID: 37908277
  25. 25

    Hereditary Hypophosphatemic Rickets with Hypercalciuria Presenting with Enthesopathy, Renal Cysts, and High Serum c-Terminal FGF23: Single-Center Experience and Systematic Review.

    Dodamani MH, Memon SS, Karlekar M, et al.

    Calcified tissue international 2024; (114(2)):137-146 doi:10.1007/s00223-023-01156-2.

    PMID: 37981601
  26. 26

    Inherited non-FGF23-mediated phosphaturic disorders: A kidney-centric review.

    Walker E, Hayes W, Bockenhauer D

    Best practice & research. Clinical endocrinology & metabolism 2024; (38(2)):101843 doi:10.1016/j.beem.2023.101843.

    PMID: 38042745
  27. 27

    An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

    Zhu Z, Bo-Ran Ho B, Chen A, et al.

    Kidney international 2024; (105(5)):1058-1076 doi:10.1016/j.kint.2024.01.031.

    PMID: 38364990
  28. 28

    Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets.

    Baroncelli GI, Grandone A, Aversa A, et al.

    European journal of medical genetics 2024; (70()):104958 doi:10.1016/j.ejmg.2024.104958.

    PMID: 38950880
  29. 29

    Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.

    Brunkhorst M, Brunkhorst L, Martens H, et al.

    Kidney international 2025; (107(1)):116-129 doi:10.1016/j.kint.2024.08.035.

    PMID: 39461557
  30. 30

    Thiazide diuretics for preventing calcium oxalate recurrent kidney stones: an updated systematic review, meta-analysis and trial sequential analysis of randomized controlled trials.

    Porto BC, Terada BD, Gonçalves FG, et al.

    Minerva urology and nephrology 2025; (77(3)):298-307 doi:10.23736/S2724-6051.25.05903-8.

    PMID: 40528770
  31. 31

    Hereditary Hypophosphatemic Rickets with Hypercalciuria-Importance of Further Evaluation when Clinical Suspicion is Strong

    Wettasinghe CA, Kumarasiri IM, Vidushajini M, et al.

    Journal of clinical research in pediatric endocrinology 2026; (18(3)):549-553 doi:10.4274/jcrpe.galenos.2025.2025-1-15.

    PMID: 40820604
  32. 32

    Refractory Rickets: Evaluation and Management.

    Krishnamurthy S

    Indian journal of pediatrics 2026; (93(6)):612-620 doi:10.1007/s12098-026-06032-z.

    PMID: 41741919
  33. 33

    Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic <italic>SLC34A3</italic> and Monoallelic <italic>SLC3A1</italic> Pathogenic Variants - Who Is "The Culprit"?

    Olarewaju BA, Sabrowsky S, Shurrab S, et al.

    Kidney & blood pressure research 2026; (51(1)):280-284 doi:10.1159/000551270.

    PMID: 41849633
  34. 34

    Two variants in SLC34A3 in a patient with X-linked hypophosphatemia: a diagnostic and therapeutic dilemma.

    Sharova M, Klimova E, Filatova A, et al.

    Pediatric nephrology (Berlin, Germany) 2026; doi:10.1007/s00467-026-07520-2.

    PMID: 42684400
  35. 35

    Late diagnosis of SLC34A3-related hereditary hypophosphatemic osteomalacia following a low-energy proximal humeral 4-part fracture.

    Morimoto T

    JBMR plus 2026; (10(10)):ziag137 doi:10.1093/jbmrpl/ziag137.

    PMID: 42741772